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Presacral Neurectomy in the 
Treatment of Chronic Pelvic Pain 
in Women
Funda Gungor Ugurlucan and Cenk Yasa
Abstract
Chronic pelvic pain affects 2–24% of women in the reproductive period. There 
are various causes of chronic pelvic pain in women including gynecologic, urologic, 
gastrointestinal, and musculoskeletal problems. The treatment of pain is directed 
toward the underlying pathology. However, in some cases, no pathology can be 
found, and sometimes, more than one underlying pathology may be found in 
the same patient. Surgical denervation methods may be used in the treatment of 
chronic pelvic pain in women including uterosacral nerve ablation and presacral 
neurectomy. Uterosacral nerve ablation has been used as a treatment method for 
uterine causes of pelvic pain. It has been used widely in the treatment of dysmenor-
rhea- and endometriosis-related pain. But recent randomized studies and meta-
analysis have questioned the effect of uterosacral nerve ablation in the treatment 
of chronic pelvic pain. Presacral neurectomy involves damage of the uterine 
sympathetic innervation at the level of superior hypogastric plexus. It is effective 
in the treatment of midline pelvic pain. It has been found to be more effective than 
laparoscopic uterosacral nerve ablation in a randomized study. The method, effect, 
and studies evaluating uterosacral nerve ablation and presacral neurectomy will be 
discussed in this chapter.
Keywords: uterosacral nerve ablation, presacral neurectomy, LUNA,  
chronic pelvic pain, dysmenorrhea
1. Introduction
Chronic pelvic pain (CPP) is a constant or recurrent pain and generally defined 
as lasting for more than 6 months, and clinically carries significant physical, 
functional, and psychological impacts that have an adverse effect on quality of life. 
This pain frequently localized to the pelvis, the anterior abdominal wall at or below 
the umbilicus, lumbosacral back, and the buttocks. Its prevalence ranges from 6.4 
to 25.4% in different countries, and about 18% of women take 1 day of sick leave 
annually due to CPP [1].
The etiology of CPP has not been clearly defined and explained. This disorder 
has multifactorial overlapping etiology, and more than 70 causes are associated with 
CPP [2]. Acute pain is a result of tissue damage and reveals simultaneously with 
healing, but chronic pain persists long after the tissue has healed or remains stable 
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in the absence of etiological factors. In chronic pain, some lesions affect the central 
and peripheral nervous system. Sometimes immunologic factors like cytokines and 
chemokines activate normally inactive fibers and cause peripheral nervous system 
dysfunction. Also, long-term pain could increase pain stimulus which is called 
visceral hyperalgesia.
Etiological factors of CPP can be divided into gynecological or non-gynecological 
causes. Endometriosis, adenomyosis, leiomyomas, ovarian tumors, pelvic inflamma-
tory disease, surgery related adhesions, and pelvic congestion syndrome are mostly 
encountered gynecologic causes. Also, surgical, urological, gastrointestinal, musculo-
skeletal, psychosomatic, and neurological problems could be causative factors of CPP.
The etiology of CPP is complex and multifactorial; therefore, extensive diagnos-
tic procedures are required. The first but maybe the most important step consists of 
history-taking and physical examination. In history-taking, the factors that induce or 
aggravate pain should be clarified. Also, effects of pain on the quality of life should 
be assessed. With the results of this initial step, imaging studies such as transvaginal 
ultrasound of the pelvis, computerized tomography (CT), magnetic resonance imag-
ing (MRI), and venography could direct diagnosis and management. Blood tests, 
bacteriological tests, and cystoscopy also may be useful in the differential diagnosis 
[3]. Last of all, diagnostic laparoscopy may be performed keeping in mind that in 1/3 
of the patients etiologic factors cannot be identified by laparoscopy.
The aim of therapy in CPP is to improve quality of life and overall function. 
Treatment is focused mainly on symptomatic relief. In the presence of obvious 
etiological factors, it should be treated. But even in these patients, targeted therapy 
may not result in resolution of pain. Because pain generators involve multiple 
mechanisms, treatment should include physical, behavioral, psychological, and 
sexual components. In the first-line management, if the underlying disease process 
is known, treatment should be directed according to specific management of this 
cause. If treatment is inadequate or the cause of pain is not known, with the phar-
macological therapy, symptomatic relief should be targeted. To do this, analgesics, 
hormonal therapy (e.g., oral contraceptive, progesterone, levonorgestrel-releasing 
intrauterine system, gonadotropin-releasing hormone agonist), tricyclic antide-
pressants, serotonin-norepinephrine reuptake inhibitors, anticonvulsants, and 
opioids are potentially useful medications. Surgical interventions, sometimes may 
be diagnostic, should be guided by the underlying diagnosis. Diagnostic laparos-
copy, conscious laparoscopic mapping, adhesiolysis, surgical excision of ovarian 
remnant, and hysterectomy are the among the most common surgical procedures in 
the management of chronic pelvic pain [4].
For the patients with CPP who desire to retain their reproductive potential, surgi-
cal pelvic denervation procedures may be useful. First, presacral neurectomy was 
described by Jourboulay and Ruggi in 1899 [5]. These procedures showed decrement 
after the increase in the use of analgesics and hormonal contraceptives. With the 
introduction of minimal invasive surgical techniques, pelvic denervation procedures 
had become popularized especially in the medical treatment-resistant patients.
Superior and inferior hypogastric nerve plexuses carry pelvic visceral pain 
through the sympathetic nervous system [6]. These afferent fibers that carry pain 
signals from the upper vagina, cervix, and uterus should be targeted for pelvic dener-
vation. The sacrouterine ligament is the point that inferior hypogastric nerve plexus 
exits the uterus. At the sacral promontory in the interiliac triangle bilateral inferior, 
hypogastric nerves come together to form the superior hypogastric plexus which 
return to the spinal cord through lumbar splanchnic nerves. Especially, the pain fibers 
from the ovary and distal fallopian tubes go through the ovarian plexus to the vagus 
nerve. Because these fibers join with the superior hypogastric plexus, pelvic denerva-
tion procedures are only indicated for patients with midline pelvic pain.
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Pelvic denervation procedures are indicated in women with chronic pelvic pain 
with a predominant midline component who desire to maintain their reproductive 
potential and fail or have contraindications to medical management [7]. Patients with 
endometriosis who have midline chronic pelvic pain, pelvic denervation interventions 
also improve pain when combined with surgical excision of endometriosis [8].
2. Presacral neurectomy
Presacral neurectomy is the surgical procedure that transects the superior 
hypogastric plexus to denervate the sensorial communication of the pelvic viscera 
and abdominal wall in order to treat refractory pelvic pain [9].
In this surgical procedure, experienced surgeons in the presacral space are 
essential. Due to known benefits of minimally invasive surgery and the advantage 
of identify potential etiologies of pelvic pain, conventional or robot-assisted 
laparoscopy is the preferred route for presacral neurectomy. Presacral space has 
close proximity to major vascular structures such as aortic bifurcation, common 
iliac arteries, left common iliac vein, and inferior mesenteric artery and ureters 
(Figure 1). The parietal peritoneum overlying the sacral promontory is incised 
transversely. Original opening is extended proximally to the point just above aortic 
bifurcation and distally to the sacral promontory. Especially, complete removal of 
fibrous and adipose tissue located between the iliac vessels is crucial because modi-
fication of procedure leads to lower than expected success rates [10]. Visualization 
of vasculature and ureters all during procedure prevents major complications.
Figure 1. 
The appearance of the presacral space.
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Cadaveric studies have revealed numerous anatomic variations of the localiza-
tion and morphology of the superior hypogastric plexus [11]. Ripperda et al. found 
that the superior hypogastric plexus was located inferior to the aortic bifurcation in 
83% of the cases and it was located superiorly in the rest [12]. Correia et al. reported 
six different morphologies of the superior hypogastric plexus [13]. These anatomic 
variations are a challenge for surgeons during presacral neurectomy.
There are no randomized controlled trials regarding presacral neurectomy in 
the treatment of CPP. Retrospective studies report success rates of 62–73% with 
this intervention, especially in patients with CPP unresponsive to other treatments 
[14, 15]. Regardless of pathologic features, improvement in midline pelvic pain is 
observed more than lateral pelvic pain [16].
Presacral neurectomy is also used in combination with endometriosis surgery. In 
these patients, additional midline pain relief related with menses but not dyspareu-
nia or nonmenstrual pain was demonstrated [17, 18]. In one randomized controlled 
trial, addition of presacral neurectomy to conservative laparoscopic surgery in 
endometriosis patients reported improvement in dysmenorrhea, dyspareunia, and 
quality of life of patients than endometriosis surgery alone [19]. Patients with mid-
line pelvic pain associated with endometriosis have greater improvement in pain if 
presacral neurectomy is added to surgical treatment of endometriosis.
Middle sacral vessels and left common iliac veins are major vascular structures more 
prone to injury. In order to prevent ureteral injury, identification of the ureter prior to 
nerve dissection is important. With the careless transection of lymphatic vessels, chylous 
ascites may be encountered. This complication could be prevented with sealing of the 
lymphatic vessels. There have been limited reports about bowel and bladder dysfunction 
with respect to this procedure. Among them constipation is very well known [20].
Hagg et al. evaluated the sexual functions of women who underwent anterior 
fusion and denervation of the superior hypogastric plexus [21]. The authors found 
disturbance in orgasm and genital sensation of 20% women who underwent 
surgery. Martin-Alguacil et al. studied the neuronal tracing from the clitoris to the 
spinal tracts in female mice and found that pudendal and hypogastric nerves had 
a major role in the innervation of the external genitalia and neuronal pathologies, 
and trauma may lead to sexual dysfunction [22]. The possible effect of presacral 
neurectomy on sexual functions should be evaluated in randomized studies.
3. Uterosacral nerve ablation
The presence of nerve fibers and ganglia in the uterosacral ligaments has been 
described in the nineteenth century [23]. Sympathetic fibers originating from 
T10 to L1 spinal roots run through the superior hypogastric plexus which is at the 
level of the aortic bifurcation in the presacral space. Nerve fibers from the superior 
hypogastric plexus split into two hypogastric nerves that course along the internal 
iliac vessels on each side and connect to the inferior hypogastric plexus.
The parasympathetic innervation derives from S1 to S4 via the pelvic splanchnic 
nerves and travels through the lateral pelvic wall to join the inferior hypogastric 
plexus and form the Frankenhauser ganglia lateral to the cervix. The inferior hypo-
gastric plexus consists of three areas: the vesical plexus, the uterovaginal plexus, 
and the middle rectal plexus.
The uterovaginal plexus receives sympathetic fibers from T10 to L1 and para-
sympathetic fibers from S1 to S4 and lies on the medial side of the uterine vessels, 
lateral to the attachment of uterosacral ligaments (Figure 2). Therefore, division 
of the uterosacral ligaments may interrupt many sensory fibers that carry painful 
stimuli of the cervix and uterine corpus.
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The technique of uterosacral nerve ablation was first described by Ruggi in 1899 
[24]. Later, Doyle evolved the technique proposed by Ruggi [5]. Doyle suggested 
that the transection of the cervical division of the Frankenhauser uterovaginal 
plexus lying in, around, and under the terminal 2.5 cm of the uterosacral ligaments 
permitted sensory denervation of the cervix and uterine fundus and the proximal 
parts of the uterine tubes. Transection of the nerve fibers did not result in auto-
nomic imbalance because both sympathetic and parasympathetic pathways were 
interrupted and the rectal and bladder functions were not affected. In Doyle’s series, 
dysmenorrhea was relieved in 69 of 73 cases (94.5%). Relief was partial in six cases 
(8.2%), and there were four failures (5.5%) [5].
Uterosacral nerve ablation may be performed through abdominal, vaginal, or 
laparoscopic routes. Laparoscopic route is called laparoscopic uterosacral nerve 
ablation (LUNA). There are huge variations in the technique of LUNA without clear 
evidence on which technique is superior to the other [25]. It has been suggested 
that division of the uterosacral ligaments approximately 1.5 cm distal to the cervix 
should interrupt many sensory nerve fibers of the cervix and uterine corpus, and 
Doyle suggested that this was possible even through the vaginal route [5]. However, 
anatomical studies showed that the majority of uterosacral nerve fibers were found 
at a distance of 6.5–33 mm and at a depth of 3–5 mm distal to the attachment site of 
the uterosacral ligaments to the cervix [26]. There are widespread variations in the 
technique performed, including the route of surgery, the site of nerve ablation, and 
the method used for nerve ablation such as laser, electrodiathermy, scissors cutting, 
or harmonic scalpel [27].
Uterine nerve ablation is performed under general anesthesia. At the beginning 
of the procedure, attention should be given to the course of the ureters and the 
Figure 2. 
The uterosacral ligaments located on the inferoposterior part of the uterus contain the nerve fibers of the 
inferior hypogastric plexus.
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neighboring vessels in order to prevent inadvertent damage. A uterine manipulator 
may aid in the visualization of the uterosacral ligaments by permitting anteflexion 
of the uterus. First, incision is made on the medial aspect of the ligament at its 
insertion to the uterus, and the second incision is made lateral to the uterosacral 
ligament and medial to the ureter. The ligament may be grasped with a forceps and 
stretched toward the lateral pelvic wall to aid in the ablation process. One or both of 
the ligaments may be transected. Full or partial transection of the ligaments may be 
done bilaterally with laser or electrodiathermy, according to the surgeons’ prefer-
ence. Laser usage may result in less thermal damage to the neighboring structures. 
The posterior part of the cervix between the insertions of the uterosacral ligaments 
may be ablated to interrupt the sensory fibers that cross to the contralateral utero-
sacral ligament. A small portion of the ligament may be transected and examined 
histologically to confirm the presence of the nerves fibers in the specimen [28].
Uterine nerve ablation may be classified as a safe operation with few complica-
tions reported in the literature; the complications such as constipation, postopera-
tive bleeding, and urinary urgency were more common with presacral neurectomy 
when compared with LUNA [29]. Potential adverse events that may be observed 
after uterosacral nerve ablation include vascular, bowel or ureteric injury, bleeding, 
the need for conversion to open surgery, and pelvic organ prolapse.
Latthe et al. evaluated the variations in the indications and surgical technique of 
LUNA among the members of the UK Royal College of Obstetrics and Gynecologists 
and European Society of Gynecological Endoscopy [30]. The most common indica-
tion for LUNA was chronic pelvic pain (68%) followed by dysmenorrhea (66%), 
endometriosis (60%), and dyspareunia (39%). The authors stated that the European 
group was more likely to perform LUNA (62 versus 21%), and the technique differed 
between the two groups. The European group completely transected the uterosacral 
ligaments (56 versus 36%) and at a distance of more than 2 cm from its cervical 
insertion (50 versus 21%) when compared to the UK group. The authors concluded 
that there was variation in the LUNA technique in Europe according to operator 
experience. In addition to variations in the technique and indications, gynecologists’ 
opinions regarding surgery for CPP may differ. Latthe et al. evaluated the gynecolo-
gists’ beliefs about the effectiveness of laparoscopic uterosacral nerve ablation using 
a structured survey [31]. Twenty-five gynecologists responded to the questionnaire; 
none stated that LUNA would increase pain, while two gynecologists stated that the 
intervention would worsen the pain. However, most of the respondents believed that 
LUNA would have a small beneficial effect on pain.
There are studies evaluating the efficacy of uterosacral nerve ablation in the 
treatment of primary or secondary dysmenorrhea, CPP related to endometriosis, 
and dyspareunia. Feste reported significant improvement in the symptoms of 
primary dysmenorrhea or dysmenorrhea associated with endometriosis in 71% of 
the patients who underwent uterosacral nerve ablation [32]. Donnez et al. reported 
complete relief in 50% and mild to moderate relief in 41% of the patients [33]. 
Davis reported significant improvement in dysmenorrhea and dyspareunia in 92 
and 94% of the patients with endometriosis who underwent uterine nerve ablation 
and vaporization of endometriosis, respectively [34]. Yen et al., in their randomized 
study, evaluated the effect of LUNA on secondary dysmenorrhea associated with 
myoma and concluded that LUNA had a beneficial effect on alleviating pain related 
to dysmenorrhea [35]. Lichten and Bombard in their randomized, prospective, 
double-blind study of the effect of LUNA on treatment-resistant dysmenorrhea 
showed complete relief in almost half of the patients 1 year after surgery [36].
Johnson et al., in their randomized study included 123 patients with chronic pel-
vic pain. There was significant reduction in dysmenorrhea, but there was no benefit 
in nonmenstrual chronic pelvic pain in patients with or without endometriosis [37]. 
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No improvement was observed on dyspareunia and dysmenorrhea. Vercellini et al., 
in their randomized study on the effect of LUNA on endometriosis-related dysmen-
orrhea, showed no reduction in the frequency and severity of dysmenorrhea [38]. 
LUNA had no additional effect on health-related quality of life, psychiatric profile, 
and sexual satisfaction. Shawki, in his randomized controlled trial, evaluated the 
efficacy and satisfaction related to LUNA in patients suffering from CPP associated 
with either no or mild endometriosis [39]. The authors found no significant differ-
ence between the groups that underwent diagnostic laparoscopy and LUNA and 
diagnostic laparoscopy only in the treatment of primary and secondary dysmenor-
rhea, but there was a significant difference regarding dyspareunia. Daniels et al., in 
their randomized controlled trial, showed that there was no significant difference 
regarding pain scores and quality of life between the LUNA group and no LUNA in 
the treatment of CPP [40].
There is only one randomized trial comparing the effect of presacral neurectomy 
and LUNA. Chen et al. compared the effect of presacral neurectomy and LUNA on 
primary dysmenorrhea [41]. Laparoscopic presacral neurectomy was more effective 
than LUNA in the long-term follow-up. In a systematic review of nine randomized 
trials on the surgical interruption of the pelvic nerve pathways, five trials investi-
gated the effect of LUNA, two trials laparoscopic presacral neurectomy, and two 
trials open presacral neurectomy [42]. For the treatment of primary dysmenorrhea, 
LUNA had a small beneficial effect when compared to control group. There was no 
significant difference between LUNA and presacral neurectomy in the treatment 
of dysmenorrhea in the short-term follow-up; however, laparoscopic presacral 
neurectomy was more effective than LUNA in the long term. LUNA was not found 
effective in the treatment of secondary dysmenorrhea.
Therefore, although initial case series have shown promising results, both 
prospective and randomized controlled studies have shown that LUNA had no sig-
nificant effect in the cure of CPP, but it may have a beneficial effect in some patients 
with pelvic pain and primary dysmenorrhea. The European Society of Human 
Reproduction and Embryology (ESHRE) guideline on management of women with 
endometriosis has suggested that clinicians should not perform LUNA as an addi-
tional procedure to conservative surgery to reduce endometriosis-associated pain 
and presacral neurectomy was effective as an additional procedure to conservative 
surgery to reduce endometriosis-associated midline pain with significant potential 
complications [43].
4. Conclusions
Pelvic denervation procedures such as presacral neurectomy and uterosacral 
nerve ablation have been evaluated in the treatment of chronic pelvic pain with or 
without endometriosis with varying results. Recent randomized trials regarding 
uterosacral nerve ablation have shown no significant benefit of uterosacral nerve 
ablation. Presacral neurectomy may be used as an adjunct in the treatment of CPP 
with or without endometriosis; however, the surgery may not have the desired 
effect due to variations in the anatomy. In addition, the beneficial effect may dimin-
ish over time due to regeneration of the nerve fibers.
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